Proteins from the Polycomb group (PcG) are epigenetic chromatin modifiers involved in
cancer development and also in the maintenance of embryonic and adult stem cells. The
therapeutic potential of stem cells and the growing conviction that tumors contain stem cells
highlights the importance of understanding the extrinsic and intrinsic circuitry controlling
stem cell fate and their connections to cancer.